AstraZeneca knocked back by FDA on Exanta
AstraZeneca has been hit by the decision of the US Food and Drug Administration (FDA) not to approve its oral anticoagulant Exanta (ximelegatran), despite the fact that it is already on the market in Europe.
Archives for September 14, 2004
Cambrex launch new protein delivery reagent
Cambrex Corporation announces the availability of a method for the non-cytotoxic delivery of biologically active cargo molecules, such as proteins, peptides, or small molecules directly into living cells providing drug R&D with an effective tool for...
Cardinal licenses tablet coating tech
Cardinal Health has entered into a licensing agreement that gives it access to an electrostatic tablet-coating process and drug delivery technologies developed by Phoqus Pharmaceuticals of the UK.
Accelrys announces merger with SciTegic
Accelrys has signed a $21.5 million (€17.6 million) agreement to merge SciTegic with one of its subsidiaries in a deal that will add additional data analysis and mining software design capabilities to Accelrys' extensive portfolio of computational and...
Inhaler tech snapped up by Boeh Ingelheim
Germany's Boehringer Ingelheim has revealed plans to buy a microtechnology specialist - STEAG microParts - to get full control of a novel inhaler for drug delivery into the lungs.
First DNA/enzyme model serves as antiviral drug target
The first molecular-scale images of DNA binding to an adenovirus enzyme, a crucial step for a virus to cause infection, have been produced, which shows how binding to DNA may stimulate the enzyme, aiding to the design of new antiviral drugs to block...
GE tests container security
GE's security business has begun testing a cost-effective container security solution for use in maritime shipping. The new product is designed to detect unauthorised access to a container, and can monitor the container in transit for signs of intrusion.
UK project provides outreach on REACH
LGC, the independent analytical laboratory, has set up an initiative alongside the UK Chemical Industries Association (CIA) to advise chemical companies how to handle the new REACH legislation.
Tecan launch LS Reloaded microarray scanner
Switzerland's Tecan has introduced the LS Reloaded, a new series of automation-friendly microarray scanners, which now includes a three-fold higher sensitivity making it ideal for drug-related ELISA and focused biomarker arrays and assays demanding...
Prozac warning heightens new treatment need
Worldwide efforts to produce a newer, safer antidepressant have never been more imperative after a US landmark ruling requires all antidepressant drugs to carry the strongest possible warning, informing the public of the risks of administering these...
Heat-controlled implants for drug delivery
A team of US researchers has developed a new microgel film that could be used to create implants that release drugs into the body - on demand - by applying small variations in heat.
New catalyst cleans up intermediate production
Japan's Showa Denko says it has developed a new catalyst for synthesising alpha-tetralone, an important intermediate in the production of pharmaceuticals and agrochemicals, which could reduce wastage.
Packaging innovations from acquisitive Bradman Lake
Automated packaging developer Bradman Lake is launching its latest robotic top load cartoner for throughputs of up to 300ppm, an innovation that the group hopes will build on its international reputation.